During Monday’s Board of Governor’s meeting, the Board voted
to purchase a new linear accelerator to better serve the hospital’s
cancer patients. The current linear accelerator, the Varian IX, purchased
in 2006, increased treatment standards to accommodate Intensity Modulated
Radiation Therapy (IMRT). This new standard of care provided Good Samaritan’s
patients with a more uniform radiation dose while limiting to dose to
surrounding tissue. The IX also brought the capability to ‘record
and verify’ treatment parameters, along with the ability to accurately
treat many different kinds of cancers and help ensure patients the highest
quality of care.
In the last 12 years; however, linear accelerator treatment machines have
become even more accurate and
now capable of providing razor-sharp focus to eradicate the cancer target.
Due to these technological advancements, Good Samaritan has decided to
replace the IX with the Varian Edge™.
“The addition of the Varian Edge Radiosurgery System is an exciting
opportunity for Good Samaritan to provide the most state of the art radiation
treatments for our patients,” said Dr. Brian Gebhardt, Radiation
Oncologist. “This system is designed to deliver highly conformal
and accurate radiation doses to tumors in the brain with a technique called
stereotactic radiosurgery as well as increase the speed and precision
of treatments for other tumors throughout the body.” Oncology patients
will also be able to make only one to three visits for radiation treatment
opposed to the two-week course of whole brain irradiation.
“With the edition of the Varian Edge™, we will be able to offer
our patients the most accurate linear accelerator on the market with sub-millimeter
accuracy and less imaging exposure,” said Jane Russell, Director
of Oncology. “I am excited for this addition to our Oncology Department.”
The purchase of the new linear accelerator, which will last Good Samaritan
10 years, will have a total cost of $2.9 million with a three-year return